Cargando…
Clinical applications of thrombopoietin silencing: A possible therapeutic role in COVID-19?
Thrombopoietin (TPO) is most recognized for its function as the primary regulator of megakaryocyte (MK) expansion and differentiation. MKs, in turn, are best known for their role in platelet production. Research indicates that MKs and platelets play an extensive role in the pathologic thrombosis at...
Autores principales: | Alentado, Vincent J., Moliterno, Alison R., Srour, Edward F., Kacena, Melissa A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8253722/ https://www.ncbi.nlm.nih.gov/pubmed/34247039 http://dx.doi.org/10.1016/j.cyto.2021.155634 |
Ejemplares similares
-
Interaction of the inflammatory response and megakaryocytes in COVID-19 infection
por: Battina, Hanisha L., et al.
Publicado: (2021) -
The Thrombopoietin Receptor, MPL, Is a Therapeutic Target of Opportunity in the MPN
por: Spivak, Jerry L., et al.
Publicado: (2021) -
Analysis of the effects of spaceflight and local administration of thrombopoietin to a femoral defect injury on distal skeletal sites
por: Zamarioli, Ariane, et al.
Publicado: (2021) -
Thrombopoietin is required for full phenotype expression in a JAK2(V617F) transgenic mouse model of polycythemia vera
por: Spivak, Jerry L., et al.
Publicado: (2020) -
Role of Thrombopoietin Receptor Agonists in Inherited Thrombocytopenia
por: Bastida, José María, et al.
Publicado: (2021)